162 related articles for article (PubMed ID: 38353838)
1. Bioactive potential of Bio-C Temp demonstrated by systemic mineralization markers and immunoexpression of bone proteins in the rat connective tissue.
Lopes CS; Delfino MM; Tanomaru-Filho M; Sasso-Cerri E; Guerreiro-Tanomaru JM; Cerri PS
J Mater Sci Mater Med; 2024 Feb; 35(1):13. PubMed ID: 38353838
[TBL] [Abstract][Full Text] [Related]
2. Hepatic enzymes and immunoinflammatory response to Bio-C Temp bioceramic intracanal medication implanted into the subcutaneous tissue of rats.
Lopes CS; Delfino MM; Tanomaru-Filho M; Sasso-Cerri E; Guerreiro-Tanomaru JM; Cerri PS
Sci Rep; 2022 Feb; 12(1):2788. PubMed ID: 35181684
[TBL] [Abstract][Full Text] [Related]
3. Bioactive potential of Bio-C Pulpo is evidenced by presence of birefringent calcite and osteocalcin immunoexpression in the rat subcutaneous tissue.
Queiroz MB; Inada RNH; Lopes CS; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
J Biomed Mater Res B Appl Biomater; 2022 Oct; 110(10):2369-2380. PubMed ID: 35583398
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Bio-C Pulpo and MTA Repair HP with White MTA: effect on liver parameters and evaluation of biocompatibility and bioactivity in rats.
Delfino MM; de Abreu Jampani JL; Lopes CS; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Sasso-Cerri E; Cerri PS
Int Endod J; 2021 Sep; 54(9):1597-1613. PubMed ID: 33999424
[TBL] [Abstract][Full Text] [Related]
5. Participation of fibroblast growth factor-1 and interleukin-10 in connective tissue repair following subcutaneous implantation of bioceramic materials in rats.
Delfino MM; Jampani JLA; Lopes CS; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Sasso-Cerri E; Cerri PS
Int Endod J; 2023 Mar; 56(3):385-401. PubMed ID: 36353742
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity, cytocompatibility and effect of Bio-C Temp bioceramic intracanal medicament on osteoblast biology.
Guerreiro JCM; Ochoa-Rodrígez VM; Rodrigues EM; Chavez-Andrade GM; Tanomaru-Filho M; Guerreiro-Tanomaru JM; Faria G
Int Endod J; 2021 Jul; 54(7):1155-1165. PubMed ID: 33638900
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility and bioactive potential of an experimental tricalcium silicate-based cement in comparison with Bio-C repair and MTA Repair HP materials.
Queiroz MB; Inada RNH; Jampani JLA; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2023 Feb; 56(2):259-277. PubMed ID: 36314136
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility and Bioactive Potential of New Calcium Silicate-based Endodontic Sealers: Bio-C Sealer and Sealer Plus BC.
Alves Silva EC; Tanomaru-Filho M; da Silva GF; Delfino MM; Cerri PS; Guerreiro-Tanomaru JM
J Endod; 2020 Oct; 46(10):1470-1477. PubMed ID: 32682789
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Assessment of the Calcium Salt-Forming Ability of a New Calcium Silicate-Based Intracanal Medicament: Bio-C Temp.
Edanami N; Belal RS; Takenaka S; Yoshiba K; Gutierrez REB; Takahara S; Yoshiba N; Ohkura N; Noiri Y
Dent J (Basel); 2023 Mar; 11(4):. PubMed ID: 37185469
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility, induction of mineralization and antimicrobial activity of experimental intracanal pastes based on glass and glass-ceramic materials.
de Araújo Lopes JM; Benetti F; Rezende GC; Souza MT; Conti LC; Ervolino E; Jacinto RC; Zanotto ED; Cintra LTA
Int Endod J; 2020 Nov; 53(11):1494-1505. PubMed ID: 32767572
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and biomineralization assessment of bioceramic-, epoxy-, and calcium hydroxide-based sealers.
Bueno CR; Valentim D; Marques VA; Gomes-Filho JE; Cintra LT; Jacinto RC; Dezan-Junior E
Braz Oral Res; 2016 Jun; 30(1):. PubMed ID: 27305513
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and immunohistochemical evaluation of a new calcium silicate-based cement, Bio-C Pulpo.
Cosme-Silva L; Gomes-Filho JE; Benetti F; Dal-Fabbro R; Sakai VT; Cintra LTA; Ervolino E; Viola NV
Int Endod J; 2019 May; 52(5):689-700. PubMed ID: 30515845
[TBL] [Abstract][Full Text] [Related]
13. Systemic bone marker expression induced by grey and white mineral trioxide aggregate in normal and diabetic conditions.
de Azevedo Queiroz IO; Mello WG; Martins CM; Dal Fabbro R; Narciso LG; Massunari L; Cintra LTA; Ervolino E; Gomes-Filho JE
Int Endod J; 2018 Aug; 51(8):889-900. PubMed ID: 29377189
[TBL] [Abstract][Full Text] [Related]
14. Mast cells and immunoexpression of FGF-1 and Ki-67 in rat subcutaneous tissue following the implantation of Biodentine and MTA Angelus.
da Fonseca TS; Silva GF; Guerreiro-Tanomaru JM; Sasso-Cerri E; Tanomaru-Filho M; Cerri PS
Int Endod J; 2019 Jan; 52(1):54-67. PubMed ID: 29975794
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, inflammation, biomineralization, and immunoexpression of IL-1β and TNF-α promoted by a new bioceramic cement.
Cosme-Silva L; Santos AFD; Lopes CS; Dal-Fabbro R; Benetti F; Gomes-Filho JE; Queiroz IOA; Ervolino E; Viola NV
J Appl Oral Sci; 2020; 28():e20200033. PubMed ID: 32785523
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pH, calcium ion release, and energy dispersive spectroscopy of a bioceramic root canal dressing.
Capitanio BL; Hashizume LN; Kuga MC; Oliveira ECG; Rosa RAD; Só GB; Só MVR
Braz Dent J; 2023; 34(4):54-61. PubMed ID: 37909642
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, Biocompatibility and Biomineralization of a New Ready-for-Use Bioceramic Repair Material.
Benetti F; Queiroz ÍOA; Cosme-Silva L; Conti LC; Oliveira SHP; Cintra LTA
Braz Dent J; 2019 Jul; 30(4):325-332. PubMed ID: 31340221
[TBL] [Abstract][Full Text] [Related]
18. Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible.
Saraiva JA; da Fonseca TS; da Silva GF; Sasso-Cerri E; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Cerri PS
Biomed Mater; 2018 Feb; 13(3):035002. PubMed ID: 29242419
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of the inflammatory response and IL-6 immunoexpression promoted by Biodentine and MTA Angelus.
da Fonseca TS; da Silva GF; Tanomaru-Filho M; Sasso-Cerri E; Guerreiro-Tanomaru JM; Cerri PS
Int Endod J; 2016 Feb; 49(2):145-53. PubMed ID: 25644518
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of intracanal medications based on calcium hydroxide.
Andolfatto C; da Silva GF; Cornélio AL; Guerreiro-Tanomaru JM; Tanomaru-Filho M; Faria G; Bonetti-Filho I; Cerri PS
ISRN Dent; 2012; 2012():904963. PubMed ID: 23320187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
